Protein Expression Systems Market Size, Share, Growth, Trends, and Global Industry Analysis: By System (Yeast Cell Expression Systems, Insect Cell Expression Systems, Prokaryotic Expression Systems, Mammalian Cell Expression Systems, Algal-based Expression Systems, Cell-free Expression Systems), By Applications (Therapeutic Applications, Industrial Application, Research Applications), By Products (Competent Cells, Instruments, Services, Reagents, Expression Vectors), By End-Users (Drug discovery contract research organization, Academics, Pharmaceutical companies), and Region

Protein Expression Systems Market size was valued at US$ 3,187.8 million in 2023 and is poised to grow at a CAGR of 10.2% from 2024-2030. The protein expression market refers to the industries that deal with the development of the technologies and products used to express and produce proteins in different biological expression systems. Protein expression systems are a fundamental and vital process in biotechnology and pharmaceutical research, as protein plays a crucial role in several biological functions, understanding disease mechanisms, drugs discovery, diagnostic testing, and therapeutic development. Recombinant proteins are created via protein expression methods, which work by inserting certain DNA sequences into host organisms. Large amounts of proteins may be produced by researchers using these systems for research, characterization, and commercial manufacturing. The market for protein expression systems includes a wide range of technologies, including cell-free, yeast, insect, and mammalian cell expression systems as well as bacterial and yeast expression systems. The increasing demand for recombinant proteins in various research and therapeutic applications coupled with the rising prevalence of chronic diseases is majorly driving the protein expression system market. Moreover, continuous advancements in genetic engineering and biotechnology, the growth of the biopharmaceutical industry, and associated research and development activities, as well as advancements in proteomics research, have led to the development of advanced protein expression systems significantly contribute to the growth of the market.

Furthermore, advancements in gene editing technologies and growing demand for biopharmaceuticals such as monoclonal antibodies, recombinant proteins, and therapeutic enzymes, provide significant opportunities for protein expression systems. However, the high costs associated with establishing and maintaining protein expression systems can pose a barrier for the growth of the market. the market players are developing innovative solutions to expand their product portfolios and meet the growing demand for protein expression technologies in various research, diagnostic, and therapeutic applications. For instance, in Mar 2022, ProteoGenix, launched a new XtenCHOTM Transient Chinese Hamster Ovary (CHO) Expression System to improve biologics development.

Protein Expression Systems Market Key Developments

• In July 2018, – Polyplus-transfection SA launched FectoCHO Expression System designed for enhanced protein production in CHO cells.